Versant Capital Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.2K Buy
912
+164
+22% +$5.03K ﹤0.01% 1787
2026
Q2
$25.9K Buy
748
+665
+801% +$17.9K ﹤0.01% 1800
2026
Q1
$1.72K Buy
83
+48
+137% +$1.13K ﹤0.01% 2586
2025
Q4
$1.14K Buy
+35
New +$1.5K ﹤0.01% 2518
2025
Q3
– Sell
-2
Closed -$100 – 2680
2025
Q2
$100 Buy
+2
New +$90 ﹤0.01% 2615
2023
Q3
– Sell
-15
Closed -$141 – 1986
2023
Q2
$141 Buy
+15
New +$149 ﹤0.01% 2017

Other funds holding HIMS

Versant Capital Management's HIMS Position: Q3 2026 in Review

Versant Capital Management increased its Hims & Hers Health (HIMS) stake by 22% in Q3 2026, buying an estimated $5.03K and bringing the position to 912 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

Versant Capital Management first reported a position in HIMS in Q2 2023 and has held it in 6 quarters since. 175 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • Versant Capital Management held 912 shares of Hims & Hers Health worth $27.2K as of Q3 2026.
  • Versant Capital Management bought 164 Hims & Hers Health shares in Q3 2026, an estimated $5.03K.
  • Hims & Hers Health made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1787 holding.
  • Versant Capital Management first reported a position in Hims & Hers Health in Q2 2023 and has held it in 6 quarters since.
  • 175 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.